JP2007039454A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007039454A5 JP2007039454A5 JP2006205679A JP2006205679A JP2007039454A5 JP 2007039454 A5 JP2007039454 A5 JP 2007039454A5 JP 2006205679 A JP2006205679 A JP 2006205679A JP 2006205679 A JP2006205679 A JP 2006205679A JP 2007039454 A5 JP2007039454 A5 JP 2007039454A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- resin
- vegetarian
- optionally
- eluate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 claims 37
- 102000004169 proteins and genes Human genes 0.000 claims 37
- 239000011347 resin Substances 0.000 claims 13
- 229920005989 resin Polymers 0.000 claims 13
- 238000000034 method Methods 0.000 claims 7
- 239000000047 product Substances 0.000 claims 6
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 5
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 5
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims 5
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 4
- 238000004587 chromatography analysis Methods 0.000 claims 4
- 230000007935 neutral effect Effects 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 3
- 241000191967 Staphylococcus aureus Species 0.000 claims 3
- 229910000162 sodium phosphate Inorganic materials 0.000 claims 3
- 239000001488 sodium phosphate Substances 0.000 claims 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims 3
- 208000023275 Autoimmune disease Diseases 0.000 claims 2
- 238000011026 diafiltration Methods 0.000 claims 2
- 239000000706 filtrate Substances 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 230000002458 infectious effect Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000008363 phosphate buffer Substances 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 229920001059 synthetic polymer Polymers 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims 1
- 206010056370 Congestive cardiomyopathy Diseases 0.000 claims 1
- 108010091326 Cryoglobulins Proteins 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 201000010046 Dilated cardiomyopathy Diseases 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 1
- 239000005909 Kieselgur Substances 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000013633 acquired hemophilia Diseases 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 238000005571 anion exchange chromatography Methods 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 229940041514 candida albicans extract Drugs 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 239000012539 chromatography resin Substances 0.000 claims 1
- 239000003480 eluent Substances 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 210000000987 immune system Anatomy 0.000 claims 1
- 239000012535 impurity Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 238000011081 inoculation Methods 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 229920000499 poly(galactose) polymer Polymers 0.000 claims 1
- 229920000193 polymethacrylate Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000003248 secreting effect Effects 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- 239000012609 strong anion exchange resin Substances 0.000 claims 1
- 239000000057 synthetic resin Substances 0.000 claims 1
- 229920003002 synthetic resin Polymers 0.000 claims 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 239000012138 yeast extract Substances 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/194,093 US7375188B2 (en) | 2005-07-29 | 2005-07-29 | Vegetarian protein a preparation and methods thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007039454A JP2007039454A (ja) | 2007-02-15 |
| JP2007039454A5 true JP2007039454A5 (enExample) | 2009-04-23 |
Family
ID=36954658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006205679A Pending JP2007039454A (ja) | 2005-07-29 | 2006-07-28 | ベジタリアンプロテインａ調製物およびその方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US7375188B2 (enExample) |
| EP (1) | EP1748063B1 (enExample) |
| JP (1) | JP2007039454A (enExample) |
| ES (1) | ES2389775T3 (enExample) |
| PL (1) | PL1748063T3 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY185597A (en) * | 2005-09-20 | 2021-05-24 | Avantor Performance Mat Inc | Vegetarian protein a preparation and methods thereof |
| CA2679983C (en) * | 2007-03-05 | 2018-10-02 | Om Pharma | Bacterial extract for digestive or urinary tract disorders and process for its preparation |
| AU2009286426B2 (en) * | 2008-08-28 | 2013-08-22 | Seqirus UK Limited | Production of squalene from hyper-producing yeasts |
| JP6170077B2 (ja) | 2012-02-16 | 2017-07-26 | エータイアー ファーマ， インコーポレイテッド | 自己免疫および炎症疾患を処置するためのヒスチジルｔＲＮＡ合成酵素 |
| ES2708565T3 (es) | 2013-03-15 | 2019-04-10 | Atyr Pharma Inc | Conjugados de Fc-histidil-ARNt sintetasa |
| JP6404821B2 (ja) * | 2013-09-12 | 2018-10-17 | 国立大学法人 岡山大学 | インターロイキン１０産生促進剤 |
| EP3612215B1 (en) | 2017-04-20 | 2024-08-28 | aTyr Pharma, Inc. | Compositions for treating lung inflammation |
| CN106977591B (zh) * | 2017-05-04 | 2020-05-05 | 广州康盛生物科技股份有限公司 | 一种分离纯化重组葡萄球菌蛋白a的方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3625833A (en) * | 1970-01-23 | 1971-12-07 | James J Schaffer | Process for producing antiviral substance from staphylococcus organisms |
| US4464165A (en) * | 1980-11-24 | 1984-08-07 | American Hoechst Corporation | Material and method for removing immunoglobulins from whole blood |
| US5151350A (en) * | 1982-10-27 | 1992-09-29 | Repligen Corporation | Cloned genes encoding recombinant protein a |
| SE8300693L (sv) * | 1983-02-09 | 1984-08-10 | Sven Lofdahl | Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta |
| US4699783A (en) * | 1983-03-11 | 1987-10-13 | Terman David S | Products and methods for treatment of cancer |
| US4617266A (en) | 1983-04-28 | 1986-10-14 | Genex Corporation | Production of Protein A |
| JPS61224997A (ja) | 1985-03-29 | 1986-10-06 | Chemo Sero Therapeut Res Inst | プロテインａの精製方法 |
| US4801687A (en) * | 1986-10-27 | 1989-01-31 | Bioprobe International, Inc. | Monoclonal antibody purification process using protein A |
| EP0289129A3 (en) | 1987-03-26 | 1990-10-10 | Repligen Corporation | High purity protein a preparation |
| ES2058538T3 (es) * | 1988-07-22 | 1994-11-01 | Imre Corp | Compuestos de proteina a purificados y procedimiento para su preparacion. |
| US6555661B1 (en) * | 1997-08-25 | 2003-04-29 | Anthony R. Torres | Simple, environmentally benign, method for purifying protein A |
| US5902722A (en) * | 1997-12-05 | 1999-05-11 | The Perkin-Elmer Corporation | Method of detecting organisms in a sample |
| US6406909B1 (en) * | 1998-07-10 | 2002-06-18 | Chugai Seiyaku Kabushiki Kaisha | Serum-free medium for culturing animal cells |
| AT409379B (de) * | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
| WO2003059935A2 (en) * | 2001-12-21 | 2003-07-24 | Immunex Corporation | Methods for purifying protein |
| US20040235139A1 (en) * | 2002-12-23 | 2004-11-25 | Demain Arnold L. | Clostridium difficile culture and toxin production methods |
| AU2004297299A1 (en) * | 2003-12-12 | 2005-06-23 | Sanofi Pasteur Limited | Production of diphtheria toxin |
| US20050282294A1 (en) * | 2004-06-17 | 2005-12-22 | Lothar Britsch | Affinity supports with immobilised protein A |
| MY185597A (en) * | 2005-09-20 | 2021-05-24 | Avantor Performance Mat Inc | Vegetarian protein a preparation and methods thereof |
-
2005
- 2005-07-29 US US11/194,093 patent/US7375188B2/en not_active Expired - Fee Related
-
2006
- 2006-07-28 JP JP2006205679A patent/JP2007039454A/ja active Pending
- 2006-07-31 PL PL06253985T patent/PL1748063T3/pl unknown
- 2006-07-31 ES ES06253985T patent/ES2389775T3/es active Active
- 2006-07-31 EP EP06253985A patent/EP1748063B1/en active Active
-
2008
- 2008-03-12 US US12/046,582 patent/US20090060904A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20180194801A1 (en) | Method for isolating and purifying recombinant human serum albumin from transgenic rice grain | |
| JPH0231689A (ja) | 百日咳トキシンの精製法 | |
| SE509359C2 (sv) | Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel | |
| CA2816050C (en) | Method for purifying human granulocyte-colony stimulating factor from recombinant e. coli | |
| WO2011015926A1 (en) | A process of fermentation, purification and production of recombinant soluble tumour necrosis factor alfa receptor (tnfr) - human igg fc fusion protein | |
| JP2549225B2 (ja) | 百日咳菌外膜蛋白質の精製方法 | |
| CN101260145B (zh) | 一种重组人血清白蛋白及其融合蛋白的分离纯化工艺 | |
| JPH07267997A (ja) | ＩｇＧ− モノクロナール抗体の精製方法及びその使用方法 | |
| JPS6262153B2 (enExample) | ||
| JP2007039454A5 (enExample) | ||
| JP3360315B2 (ja) | ヒト血清アルブミンの高度精製方法 | |
| JPH05176789A (ja) | Ｎ−末端にメチオニンを含有しない、遺伝子組換えによるヒト・システイン非含有γ− インターフェロンの製造方法 | |
| CN103242434B (zh) | 无细胞百日咳疫苗的制备方法 | |
| WO2023024214A1 (zh) | 纯化重组人血清白蛋白的融合蛋白的方法 | |
| WO2007035341A1 (en) | Protein a production and purification without using animal derived components | |
| EP1748063B1 (en) | Protein A production and purification without using animal derived components | |
| JP3805378B2 (ja) | ｒＤＳＰＡα１の製造の方法 | |
| KR100531670B1 (ko) | 인체 인터페론 알파의 제조방법 | |
| CA2084186C (en) | Purification of human interleukin-4 secreted from a escherichia coli mutant | |
| CN112175063B (zh) | 一种高效液相色谱法制备高纯度重组表皮生长因子的工艺 | |
| JP6115126B2 (ja) | ヒトＩｇＧ３の精製方法 | |
| WO2011015919A1 (en) | A highly efficient process of purification and production of recombinant infliximab | |
| CN103898123A (zh) | 重组人IFN-β-1a及其生产和纯化方法 | |
| US20020015711A1 (en) | Purification of a pertussis outer membrane protein | |
| CN105695495B (zh) | 一种高活性人趋化因子的制备方法及用途 |